Diagnostic Trends and Geographic Health Care Disparities Among Patients With Transthyretin Amyloid Cardiomyopathy
Journal of the American Heart Association · 16.06.2026 · 15 (12)
DOI: 10.1161/jaha.125.048943 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Heart Association, erschienen am 16.06.2026. Verfasst von Joshua D Mitchell und 6 weiteren Autor:innen. Beteiligte Einrichtung: Amyloid Center of Excellence, Cardiovascular Division Washington University School of Medicine St. Louis MO USA. Hauptthemen laut MEDLINE: Healthcare Disparities, Amyloid Neuropathies, Familial, Cardiomyopathies. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Transthyretin amyloid cardiomyopathy (ATTR‐CM) is a rare, life‐threatening form of restrictive cardiomyopathy. Access to cardiology providers and specialized amyloid centers may impact ATTR‐CM diagnosis. We sought to elucidate diagnostic disparities of ATTR‐CM through assessment of diagnostic trends and the geographic distribution of amyloid centers and cardiology providers in the United States.
Methods
This was a cross‐sectional geospatial analysis of amyloid centers and cardiology providers and a retrospective cohort analysis of patients with ATTR‐CM from the Komodo Healthcare Map from July 1, 2016, to June 30, 2024.
Results
Among 14 980 patients, mean age was 74.8 years, 62.3% were men, 54.1% were White individuals, and 28.8% were Black individuals. The diagnosed prevalence of ATTR‐CM was 35.68 per 100 000 persons. Prevalence was highest in Black patients (102.17) and in the Northeast (52.63), and it increased 4‐fold over the study period. Mean distance of patients to a cardiology provider was 4.3 miles and to an amyloid center was 48.5 miles. Large areas of the country, particularly in the Midwest, were identified with limited cardiology providers and amyloid centers.
Conclusions
The prevalence of ATTR‐CM has increased substantially since 2017, with notable racial differences; however, there remain geographic disparities. Strategies to address these regional disparities need to be identified.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Amyloid Center of Excellence, Cardiovascular Division Washington University School of Medicine St. Louis MO USA.
- Stanford Amyloid Center, Division of Cardiovascular Medicine Stanford University School of Medicine Stanford CA USA.
- Genesis Research Group Hoboken NJ USA.
- BridgeBio Pharma, Inc. San Francisco CA USA.
- Department of Medicine, Division of Cardiology University of Washington Seattle WA USA.
ORCID-Profile: Joshua D Mitchell, Kevin M Alexander, Hanh Dung Dao, Margarita Udall
Zitieren
APA
Mitchell, J. D., Alexander, K. M., Dao, H. D., Nagelhout, E., Lamarre, N., Udall, M., & Cheng, R. K. (2026). Diagnostic Trends and Geographic Health Care Disparities Among Patients With Transthyretin Amyloid Cardiomyopathy. Journal of the American Heart Association, 15(12). https://doi.org/10.1161/jaha.125.048943
Vancouver
Mitchell JD, Alexander KM, Dao HD, Nagelhout E, Lamarre N, Udall M, et al. Diagnostic Trends and Geographic Health Care Disparities Among Patients With Transthyretin Amyloid Cardiomyopathy. Journal of the American Heart Association. 2026;15(12). doi:10.1161/jaha.125.048943
BibTeX
@article{Mitchell2026,
author = {Mitchell, Joshua D and Alexander, Kevin M and Dao, Hanh Dung and Nagelhout, Elizabeth and Lamarre, Neil and Udall, Margarita and Cheng, Richard K},
title = {Diagnostic Trends and Geographic Health Care Disparities Among Patients With Transthyretin Amyloid Cardiomyopathy},
journal = {Journal of the American Heart Association},
year = {2026},
volume = {15},
number = {12},
doi = {10.1161/jaha.125.048943}
}
EUVIMED